Temple University Hospital performs nation's 1st post-FDA approval BLVR using Zephyr Valve

(Temple University Health System) Temple University Hospital has become the first US center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to treat severe emphysema following US FDA approval.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2L7fw8U